Stockscreener 앱 받기
2.84
0.00%
0.00
시간 외 거래:
2.84
전일 마감가:
$2.84
열려 있는:
$2.85
하루 거래량:
39,523
Relative Volume:
0.78
시가총액:
$86.59M
수익:
$4.01M
순이익/손실:
$-38.53M
주가수익비율:
-2.254
EPS:
-1.26
순현금흐름:
$-32.27M
1주 성능:
-6.58%
1개월 성능:
-10.13%
6개월 성능:
-58.42%
1년 성능:
-66.03%
1일 변동 폭
$2.81
$2.955
1주일 범위
$2.81
$3.09
52주 변동 폭
$2.65
$8.6352
Xbiotech Inc Stock (XBIT) Company Profile
명칭
Xbiotech Inc
전화
512-386-2900
주소
5217 WINNEBAGO LANE, AUSTIN, TX
XBIT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.84 | 90.85M | 4.01M | -38.53M | -32.27M | -1.26 |
|
ONC
Beigene Ltd Adr
|
241.43 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-06-14 | 개시 | Piper Jaffray | Overweight |
| 2017-04-21 | 다운그레이드 | Noble Financial | Buy → Hold |
| 2016-06-28 | 재확인 | Noble Financial | Buy |
Xbiotech Inc 주식(XBIT)의 최신 뉴스
XBiotech (NASDAQ:XBIT) Shares Cross Below 50 Day Moving AverageWhat's Next? - MarketBeat
Here's Why We're Not Too Worried About XBiotech's (NASDAQ:XBIT) Cash Burn Situation - Yahoo Finance
Barclays PLC Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World
XBiotech: Q1 Earnings Snapshot - New Haven Register
XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Shares Acquired by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Acquires 5,930 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World
JPMorgan Chase & Co. Buys 2,250 Shares of Permian Basin Royalty Trust (NYSE:PBT) - Defense World
JPMorgan Chase & Co. Trims Stake in Clipper Realty Inc. (NYSE:CLPR) - Defense World
XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageShould You Sell? - MarketBeat
Investor Network: XBiotech, Inc. to Host Earnings Call - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Stock Passes Below Fifty Day Moving AverageWhat's Next? - MarketBeat
Top Premarket Gainers - marketscreener.com
XBiotech (NASDAQ:XBIT) Shares Pass Above Fifty Day Moving AverageHere's Why - MarketBeat
XBiotech Inc. (NASDAQ:XBIT) Shares Sold by American Century Companies Inc. - Defense World
XBiotech stock plunges to 52-week low at $2.91 amid market challenges - Investing.com Canada
XBiotech Inc. (NASDAQ:XBIT) Short Interest Down 23.1% in March - MarketBeat
XBiotech Announces Board Member Retirement - TipRanks
XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving AverageWhat's Next? - MarketBeat
Bank of New York Mellon Corp Has $360,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT - ACCESS Newswire
XBiotech (NASDAQ:XBIT) Issues Quarterly Earnings Results - MarketBeat
XBiotech Inc. (XBIT) reports earnings - Quartz
Stocks Recover Some of This Week’s Losses as US Shutdown Seems Averted - TradingView
Stocks Rally as US Government Shutdown Risks Recede - TradingView
Tariff Worries Pressure Stocks - TradingView
XBiotech Inc.'s (NASDAQ:XBIT) 18% gain last week benefited both retail investors who own 49% as well as insiders - Simply Wall St
XBIT ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of XBiotech Inc. Shareholders Who Lost Money - ACCESS Newswire
Xbiotech Inc (XBIT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
17.27%
1.06%
자본화:
|
볼륨(24시간):